US Patent Issued to Chemistry RX on June 24 for "Compositions and methods for treating vascular anomalies, nevus sebaceous syndrome, epidermal nevi, and neurofibromas" (New York Inventor)

ALEXANDRIA, Va., June 25 -- United States Patent no. 12,336,997, issued on June 24, was assigned to Chemistry RX (Folcraft, Pa.).

"Compositions and methods for treating vascular anomalies, nevus sebaceous syndrome, epidermal nevi, and neurofibromas" was invented by Lars Brichta (Brooklyn, N.Y.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Compositions and methods for treating congenital epidermal or dermal hyperplasia by using topically administered oncokinase inhibitors such as trametinib, pyrrole derivatives, TAK-733, CH4987655, RDEA119/BAY 869766, cobimetinib, binimetinib, selumetinib, and the like are described herein."

The patent was filed on June 12, 2023, under Application No. 18/333,375.

*For furt...